Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-23-000011
Filing Date
2023-01-05
Accepted
2023-01-05 18:06:21
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167295996189260.html 4  
1 FORM 4 wf-form4_167295996189260.xml 4 3982
  Complete submission text file 0001615219-23-000011.txt   5441
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address
HANISH ARNOLD C (Reporting) CIK: 0001233253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 23512808

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations